Second, S100A8/A9 promote a pro-inflammatory yet immunosuppressive tumor microenvironment by recruiting and polarizing myeloid populations (e.g., myeloid-derived suppressor cells, Tumor-associated macrophages) and upregulating immune checkpoint molecules, which can impair the efficacy of immune checkpoint blockade (64). The gene discussed is S100A8; the disease is neoplasm.